1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. ARCUTIS BIOTHERAPEUTICS INC
Arcutis Biotherapeutics Inc XNAS: ARQT
25.31 0.39 (1.57%)
2.3M
XNAS Volume

XNAS 31 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The next board meeting for Arcutis Biotherapeutics Inc is on 12 Nov 2025 for the purpose of TD Cowen Immunology & Inflammation Summit See details

Arcutis Biotherapeutics Inc - ARQT - stock price prediction, stock price target, analyst ratings from 8 analysts

Arcutis Biotherapeutics Inc has a share price target of US$ 29, revenue growth forecast of 81.6%, and profit growth estimate of 58.9% for FY25, based on top 8 analyst calls.